![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
IV PUSH ADMINISTRATION OF IBALIZUMAB:
PHARMACOKINETICS, SAFETY, AND EFFICACY
|
|
|
CROI 2022 Feb 11-16
Edwin DeJesus1, Gary Richmond2, Mezgebe Berhe3, Anthony Mills4, Tanya Schreibman5, Charlotte-Paige Rolle1, Kuei-Ling Kuo6, Mohammed Zogheib7, Olivia G. Goss7,
R. Brandon Cash8, YingAn Lai6, Martin Markowitz6, Pedro M. Mesquita8
![0214221](../images/021422/021422-5/0214221.gif)
![0214222](../images/021422/021422-5/0214222.gif)
![0214223](../images/021422/021422-5/0214223.gif)
![0214224](../images/021422/021422-5/0214224.gif)
![0214225](../images/021422/021422-5/0214225.gif)
![0214226](../images/021422/021422-5/0214226.gif)
![0214227](../images/021422/021422-5/0214227.gif)
![0214228](../images/021422/021422-5/0214228.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|